LifeVantage (LFVN) Stock Overview
Engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre- and pro-biotics and skin and hair care products. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
LFVN passed our risk checks.
LFVN Community Fair Values
Create NarrativeSee what 28 others think this stock is worth. Follow their fair value or set your own to get alerts.
LifeVantage Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.34 |
| 52 Week High | US$27.38 |
| 52 Week Low | US$8.05 |
| Beta | 0.29 |
| 1 Month Change | -22.57% |
| 3 Month Change | -45.39% |
| 1 Year Change | -45.63% |
| 3 Year Change | 89.66% |
| 5 Year Change | -33.99% |
| Change since IPO | -70.04% |
Recent News & Updates
Recent updates
It's Down 25% But LifeVantage Corporation (NASDAQ:LFVN) Could Be Riskier Than It Looks
Sep 30
LifeVantage (NASDAQ:LFVN) Will Pay A Dividend Of $0.045
Sep 05The LifeVantage Advantage: High Retention, High Returns
Jul 21Shareholders Can Be Confident That LifeVantage's (NASDAQ:LFVN) Earnings Are High Quality
May 13What You Can Learn From LifeVantage Corporation's (NASDAQ:LFVN) P/E After Its 26% Share Price Crash
May 02
New Initiatives Will Drive MindBody GLP-1 System's Future Success
Expansion into international markets and enhanced supply chain capacity are expected to drive significant revenue growth and stabilize future sales.LifeVantage (NASDAQ:LFVN) Will Pay A Dividend Of $0.04
Feb 09LifeVantage Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Feb 07LifeVantage: Post-Earnings Sell-Off Provides Buying Opportunity
Feb 06LifeVantage Corporation (NASDAQ:LFVN) Looks Just Right With A 33% Price Jump
Feb 05What Is LifeVantage Corporation's (NASDAQ:LFVN) Share Price Doing?
Feb 01Market Participants Recognise LifeVantage Corporation's (NASDAQ:LFVN) Earnings Pushing Shares 31% Higher
Dec 20LifeVantage (NASDAQ:LFVN) Will Be Hoping To Turn Its Returns On Capital Around
Dec 16LifeVantage's (NASDAQ:LFVN) Dividend Will Be $0.04
Nov 16LifeVantage's (NASDAQ:LFVN) Dividend Will Be $0.04
Nov 02Subdued Growth No Barrier To LifeVantage Corporation (NASDAQ:LFVN) With Shares Advancing 63%
Sep 29We Think LifeVantage's (NASDAQ:LFVN) Solid Earnings Are Understated
Sep 05LifeVantage Corporation (NASDAQ:LFVN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
Aug 15Some Investors May Be Worried About LifeVantage's (NASDAQ:LFVN) Returns On Capital
Aug 02Is There Now An Opportunity In LifeVantage Corporation (NASDAQ:LFVN)?
Jul 15LifeVantage Corporation (NASDAQ:LFVN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
May 30The Returns On Capital At LifeVantage (NASDAQ:LFVN) Don't Inspire Confidence
Apr 22When Should You Buy LifeVantage Corporation (NASDAQ:LFVN)?
Mar 27LifeVantage Corporation (NASDAQ:LFVN) Surges 32% Yet Its Low P/S Is No Reason For Excitement
Mar 02Shareholder Returns
| LFVN | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -14.0% | -2.7% | -0.9% |
| 1Y | -45.6% | -9.5% | 20.1% |
Return vs Industry: LFVN underperformed the US Personal Products industry which returned -13.4% over the past year.
Return vs Market: LFVN underperformed the US Market which returned 20.3% over the past year.
Price Volatility
| LFVN volatility | |
|---|---|
| LFVN Average Weekly Movement | 6.6% |
| Personal Products Industry Average Movement | 8.2% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: LFVN has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: LFVN's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 235 | Steve Fife | www.lifevantage.com |
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre- and pro-biotics and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM & Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name.
LifeVantage Corporation Fundamentals Summary
| LFVN fundamental statistics | |
|---|---|
| Market cap | US$103.94m |
| Earnings (TTM) | US$9.81m |
| Revenue (TTM) | US$228.53m |
Is LFVN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LFVN income statement (TTM) | |
|---|---|
| Revenue | US$228.53m |
| Cost of Revenue | US$44.86m |
| Gross Profit | US$183.67m |
| Other Expenses | US$173.86m |
| Earnings | US$9.81m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Nov 04, 2025
| Earnings per share (EPS) | 0.77 |
| Gross Margin | 80.37% |
| Net Profit Margin | 4.29% |
| Debt/Equity Ratio | 0% |
How did LFVN perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/03 06:34 |
| End of Day Share Price | 2025/11/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
LifeVantage Corporation is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ilya Zubkov | Freedom Broker |
| Mitchell Pinheiro | Imperial Capital |
| Justin Ruiss | Sidoti & Company, LLC |